HSP90B1 and lung adenocarcinoma: Similarly, Viagenpumatucel-L (HS-110) is an allogeneic cellular vaccine obtained by transfecting the DNA of the gp96-Ig fusion protein into human lung adenocarcinoma (AD) cell lines [32].